PROTEOGLYCANS PRODUCED BY CHOLESTEROL-ENRICHED MACROPHAGES BIND PLASMA LOW-DENSITY-LIPOPROTEIN

被引:13
|
作者
OWENS, RT [1 ]
WAGNER, WD [1 ]
机构
[1] BOWMAN GRAY SCH MED,DEPT COMPARAT MED,MED CTR BLVD,WINSTON SALEM,NC 27157
关键词
MACROPHAGES; PROTEOGLYCANS; ATHEROSCLEROSIS; LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN-LDL COMPLEX;
D O I
10.1016/0021-9150(91)90170-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proteoglycans (PG) produced by [S-35]sulfate and [H-3]serine labeled cultures of cholesterol-enriched macrophages obtained from atherosclerosis-susceptible White Carneau (WC) and -resistant Show Racer (SR) pigeons were characterized and assessed for their capacity to bind low density lipoprotein (LDL). The majority of S-35-labeled PG was released into the culture media in both WC and SR macrophage cultures and consisted of large and small size PG as determined by Sepharose CL-4B chromatography. Large PG were identified as chondroitin sulfate-PG comprised of 4-sulfated disaccharides whereas small PG consisted of primarily 4-sulfated chondroitin sulfate-PG and lesser amounts of heparin sulfate-PG. Experiments demonstrated that 32-34% of S-35-labeled large PG and 86-93% of small PG bound to LDL-substituted Sepharose. Interactions between PG and LDL-substituted Sepharose were inhibited in the presence of heparin or soluble LDL. Glycosaminoglycans derived from macrophage PG had a decreased binding affinity demonstrating the importance of an intact PG. The results suggest that macrophage PG may facilitate trapping of LDL in the intimal intima and promote foam cell formation through a mechanism involving the uptake of PG-LDL complexes.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 50 条
  • [31] EFFECT OF VERAPAMIL AND NIFEDIPINE ON CHOLESTERYL ESTER METABOLISM AND LOW-DENSITY-LIPOPROTEIN OXIDATION IN MACROPHAGES
    DUSHKIN, MI
    SCHWARTZ, YS
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (03) : 389 - 397
  • [32] THE EFFECT OF SERUM ON LOW-DENSITY-LIPOPROTEIN METABOLISM OF HUMAN MONOCYTE-DERIVED MACROPHAGES
    KOTAKE, H
    OIKAWA, S
    NAITO, T
    HAYASAKA, K
    TOYOTA, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 171 (04) : 285 - 295
  • [33] GLUCOSE-ENRICHED MEDIUM ENHANCES CELL-MEDIATED LOW-DENSITY-LIPOPROTEIN PEROXIDATION
    MAZIERE, C
    AUCLAIR, M
    ROSEROBERT, F
    LEFLON, P
    MAZIERE, JC
    FEBS LETTERS, 1995, 363 (03) : 277 - 279
  • [34] HIGH-DENSITY-LIPOPROTEIN INHIBITS THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    PARTHASARATHY, S
    BARNETT, J
    FONG, LG
    BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1044 (02) : 275 - 283
  • [35] THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY HUMAN-LYMPHOCYTES
    LAMB, DJ
    WILKINS, GM
    LEAKE, DS
    ATHEROSCLEROSIS, 1992, 92 (2-3) : 187 - 192
  • [36] THE OXIDATION OF LOW-DENSITY-LIPOPROTEIN BY CELLS OR IRON IS INHIBITED BY ZINC
    WILKINS, GM
    LEAKE, DS
    FEBS LETTERS, 1994, 341 (2-3) : 259 - 262
  • [37] SPECIFICITY OF THE LOW-DENSITY-LIPOPROTEIN GLYCOSAMINOGLYCAN INTERACTION
    SAMBANDAM, T
    BAKER, JR
    CHRISTNER, JE
    EKBORG, SL
    ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (03): : 561 - 568
  • [38] DESIALYLATED LOW-DENSITY-LIPOPROTEIN - NATURALLY-OCCURRING MODIFIED LIPOPROTEIN WITH ATHEROGENIC POTENCY
    OREKHOV, AN
    TERTOV, VV
    MUKHIN, DN
    ATHEROSCLEROSIS, 1991, 86 (2-3) : 153 - 161
  • [39] LOW-DENSITY-LIPOPROTEIN IS SATURABLE BY PROOXIDANT COPPER
    GIESEG, SP
    ESTERBAUER, H
    FEBS LETTERS, 1994, 343 (03) : 188 - 194
  • [40] PRESENCE OF AUTOANTIBODIES AGAINST OXIDATIVELY MODIFIED LOW-DENSITY-LIPOPROTEIN IN ESSENTIAL-HYPERTENSION - A BIOCHEMICAL SIGNATURE OF AN ENHANCED IN-VIVO LOW-DENSITY-LIPOPROTEIN OXIDATION
    MAGGI, E
    MARCHESI, F
    RAVETTA, V
    MARTIGNONI, A
    FINARDI, G
    BELLOMO, G
    JOURNAL OF HYPERTENSION, 1995, 13 (01) : 129 - 138